|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bass BL: RNA editing by adenosine
deaminases that act on RNA. Annu Rev Biochem. 71:817–846. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nishikura K: Functions and regulation of
RNA editing by ADAR deaminases. Annu Rev Biochem. 79:321–349. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hundley HA and Bass BL: ADAR editing in
double-stranded UTRs and other noncoding RNA sequences. Trends
Biochem Sci. 35:377–383. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu H, Golji J, Brodeur LK, Chung FS, Chen
JT, deBeaumont RS, Bullock CP, Jones MD, Kerr G, Li L, et al:
Tumor-derived IFN triggers chronic pathway agonism and sensitivity
to ADAR loss. Nat Med. 25:95–102. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gannon HS, Zou T, Kiessling MK, Gao GF,
Cai D, Choi PS, Ivan AP, Buchumenski I, Berger AC, Goldstein JT, et
al: Identification of ADAR1 adenosine deaminase dependency in a
subset of cancer cells. Nat Commun. 9:54502018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun Y, Fan J, Wang B, Meng Z, Ren D, Zhao
J, Liu Z, Li D, Jin X and Wu H: The aberrant expression of ADAR1
promotes resistance to BET inhibitors in pancreatic cancer by
stabilizing c-Myc. Am J Cancer Res. 10:148–163. 2020.PubMed/NCBI
|
|
8
|
Liu X, Fu Y, Huang J, Wu M, Zhang Z, Xu R,
Zhang P, Zhao S, Liu L and Jiang H: ADAR1 promotes the
epithelial-to-mesenchymal transition and stem-like cell phenotype
of oral cancer by facilitating oncogenic microRNA maturation. J Exp
Clin Cancer Res. 38:3152019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ishizuka JJ, Manguso RT, Cheruiyot CK, Bi
K, Panda A, Iracheta-Vellve A, Miller BC, Du PP, Yates KB, Dubrot
J, et al: Loss of ADAR1 in tumours overcomes resistance to immune
checkpoint blockade. Nature. 565:43–48. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cornford P, van den Bergh RCN, Briers E,
Van den Broeck T, Cumberbatch MG, De Santis M, Fanti S, Fossati N,
Gandaglia G, Gillessen S, et al: EAU-EANM-ESTRO-ESUR-SIOG
Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of
Relapsing and Metastatic Prostate Cancer. Eur Urol. 79:263–282.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yuan Y, Li X, Xu Y, Zhao H, Su Z, Lai D,
Yang W, Chen S, He Y, Li X, et al: Mitochondrial E3 ubiquitin
ligase 1 promotes autophagy flux to suppress the development of
clear cell renal cell carcinomas. Cancer Sci. 110:3533–3542. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guo Y, Balasubramanian B, Zhao ZH and Liu
WC: Marine algal polysaccharides alleviate aflatoxin B1-induced
bursa of Fabricius injury by regulating redox and apoptotic
signaling pathway in broilers. Poult Sci. 100:844–857. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu WC, Ou BH, Liang ZL, Zhang R and Zhao
ZH: Algae-derived polysaccharides supplementation ameliorates heat
stress-induced impairment of bursa of Fabricius via modulating
NF-κB signaling pathway in broilers. Poult Sci. 100:1011392021.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao Y, Balasubramanian B, Guo Y, Qiu SJ,
Jha R and Liu WC: Dietary Enteromorpha polysaccharides
supplementation improves breast muscle yield and is associated with
modification of mRNA transcriptome in broiler chickens. Front Vet
Sci. 8:6639882021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu WC, Guo Y, Zhihui Z, Jha R and
Balasubramanian B: Algae-derived polysaccharides promote growth
performance by improving antioxidant capacity and intestinal
barrier function in broiler chickens. Front Vet Sci. 7:6013362020.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The eighth edition AJCC cancer staging manual:
Continuing to build a bridge from a population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Benne R, Van Den Burg J, Brakenhoff JP,
Sloof P, Van Boom JH and Tromp MC: Major transcript of the
frameshifted coxll gene from trypanosome mitochondria contains four
nucleotides that are not encoded in the DNA. Cell. 46:819–826.
1986. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kung CP, Maggi LB Jr and Weber JD: The
role of RNA editing in cancer development and metabolic disorders.
Front Endocrinol (Lausanne). 9:7622018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dominissini D, Moshitch-Moshkovitz S,
Amariglio N and Rechavi G: Adenosine-to-inosine RNA editing meets
cancer. Carcinogenesis. 32:1569–1577. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nishikura K: A-to-I editing of coding and
non-coding RNAs by ADARs. Nat Rev Mol Cell Biol. 17:83–96. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu LD and Öhman M: ADAR1 editing and its
role in cancer. Genes (Basel). 10:122018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Paz-Yaacov N, Bazak L, Buchumenski I,
Porath HT, Danan-Gotthold M, Knisbacher BA, Eisenberg E and Levanon
EY: Elevated RNA editing activity is a major contributor to
transcriptomic diversity in tumors. Cell Rep. 13:267–276. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kung CP, Cottrell KA, Ryu S, Bramel ER,
Kladney RD, Bao EA, Freeman EC, Sabloak T, Maggi L Jr and Weber JD:
Evaluating the therapeutic potential of ADAR1 inhibition for
triple-negative breast cancer. Oncogene. 40:189–202. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sakurai M, Shiromoto Y, Ota H, Song C,
Kossenkov AV, Wickramasinghe J, Showe LC, Skordalakes E, Tang HY,
Speicher DW and Nishikura K: ADAR1 controls apoptosis of stressed
cells by inhibiting Staufen1-mediated mRNA decay. Nat Struct Mol
Biol. 24:534–543. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Walkley CR and Kile BT: Cell death
following the loss of ADAR1 mediated A-to-I RNA editing is not
effected by the intrinsic apoptosis pathway. Cell Death Dis.
10:9132019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li J and Yuan J: Caspases in apoptosis and
beyond. Oncogene. 27:6194–6206. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liang H, Salinas RA, Leal BZ,
Kosakowska-Cholody T, Michejda CJ, Waters SJ, Herman TS,
Woynarowski JM and Woynarowska BA: Caspase-mediated apoptosis and
caspase-independent cell death induced by irofulven in prostate
cancer cells. Mol Cancer Ther. 3:1385–1396. 2004.PubMed/NCBI
|
|
29
|
Collins PL, Purman C, Porter SI, Nganga V,
Saini A, Hayer KE, Gurewitz GL, Sleckman BP, Bednarski JJ, Bassing
CH and Oltz EM: DNA double-strand breaks induce H2Ax
phosphorylation domains in a contact-dependent manner. Nat Commun.
11:31582020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Talasz H, Helliger W, Sarg B, Debbage PL,
Puschendorf B and Lindner H: Hyperphosphorylation of histone H2A. X
and dephosphorylation of histone H1 subtypes in the course of
apoptosis. Cell Death Differ. 9:27–39. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Firsanov DV, Solovjeva LV and Svetlova MP:
H2AX phosphorylation at the sites of DNA double-strand breaks in
cultivated mammalian cells and tissues. Clin Epigenetics.
2:283–297. 2011. View Article : Google Scholar : PubMed/NCBI
|
